<DOC>
	<DOCNO>NCT00452322</DOCNO>
	<brief_summary>Treatment male hypogonadism testosterone substitution monitor term safety . This study relate safety new long-acting preparation .</brief_summary>
	<brief_title>Safety Testosterone Undecanoate i.m . Hypogonadal Men</brief_title>
	<detailed_description>A reliable form androgen substitution therapy regard kinetics , tolerance restoration androgenicity paramount hypogonadal men . Intramuscular injection long-acting ester testosterone undecanoate ( TU ) offer new modality . The objective ass safety TU regard metabolic pharmacogenetic confounders hypogonadal men treat new formulation . This longitudinal prospective one-arm open intervention observation trial . A minimum 5 individual assessment prerequisite . Investigated modulators safety parameter enter regression model : nadir and/or delta total testosterone concentration , body mass index ( BMI ) , age . The set Andrological outpatient department .</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Men present hypogonadismrelated symptom desire substitution therapy . Such symptom fatigue , loss libido , depressiveness , change body composition/weight , decreased physical performance , decrease aggressive behaviour , disability cope , decreased work performance , lack androgenization . At least one symptom accompany low total testosterone level ( &lt; 12 nmol / L ) . All patient give write informed consent use data scientific evaluation approve Ethics Committee Medical Faculty , University Muenster , Germany State Medical Board . Prostate Cancer Breast Cancer Desired Paternity</criteria>
	<gender>Male</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Testosterone</keyword>
	<keyword>Hypogonadism</keyword>
	<keyword>Safety</keyword>
</DOC>